» Articles » PMID: 38862228

Cohort Profile of BIGPROMISE: a Perioperative Biobank of a High-risk Surgical Population

Overview
Journal BMJ Open
Specialty General Medicine
Date 2024 Jun 11
PMID 38862228
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Postoperative complications increase mortality, disability and costs. Advanced understanding of the risk factors for postoperative complications is needed to improve surgical outcomes. This paper discusses the rationale and profile of the BIGPROMISE (biomarkers to guide perioperative management and improve outcome in high-risk surgery) cohort, that aims to investigate risk factors, pathophysiology and outcomes related to postoperative complications.

Participants: Adult patients undergoing major surgery in two tertiary teaching hospitals. Clinical data and blood samples are collected before surgery, at the end of surgery and on the first, second and third postoperative day. At each time point a panel of cardiovascular, inflammatory, renal, haematological and metabolic biomarkers is assessed. Aliquots of plasma, serum and whole blood of each time point are frozen and stored. Data on severe complications are prospectively collected during 30 days after surgery. Functional status is assessed before surgery and after 120 days using the WHO Disability Assessment Schedule (WHODAS) 2.0. Mortality is followed up until 2 years after surgery.

Findings To Date: The first patient was enrolled on 8 October 2021. Currently (1 January 2024) 3086 patients were screened for eligibility, of whom 1750 (57%) provided informed consent for study participation. Median age was 66 years (60; 73), 28% were female, and 68% of all patients were American Society of Anaesthesiologists (ASA) physical status class 3. Most common types of major surgery were cardiac (49%) and gastro-intestinal procedures (26%). The overall incidence of 30-day severe postoperative complications was 16%.

Future Plans: By the end of the recruitment phase, expected in 2026, approximately 3000 patients with major surgery will have been enrolled. This cohort allows us to investigate the role of pathophysiological perioperative processes in the cause of postoperative complications, and to discover and develop new biomarkers to improve risk stratification for adverse postoperative outcomes.

Trial Registration Number: NCT05199025.

References
1.
Khuri S, Henderson W, DePalma R, Mosca C, Healey N, Kumbhani D . Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005; 242(3):326-41. PMC: 1357741. DOI: 10.1097/01.sla.0000179621.33268.83. View

2.
Verwijmeren L, Noordzij P, Daeter E, Emmelot-Vonk M, Vernooij L, van Klei W . Preoperative frailty and one-year functional recovery in elderly cardiac surgery patients. J Thorac Cardiovasc Surg. 2022; 166(3):870-878.e6. DOI: 10.1016/j.jtcvs.2022.01.032. View

3.
Lurati Buse G, Pinto B, Abelha F, Abbott T, Ackland G, Afshari A . ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation. Eur J Anaesthesiol. 2023; 40(12):888-927. DOI: 10.1097/EJA.0000000000001865. View

4.
Riley R, Snell K, Ensor J, Burke D, Harrell Jr F, Moons K . Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med. 2018; 38(7):1276-1296. PMC: 6519266. DOI: 10.1002/sim.7992. View

5.
Dindo D, Demartines N, Clavien P . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-13. PMC: 1360123. DOI: 10.1097/01.sla.0000133083.54934.ae. View